---
title: "XTALPI expects revenue of 800 million in 2025: operating profit of 55.24 million, just issued HKD 2.9 billion bonds"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/280713323.md"
description: "XTALPI Limited (stock code: 2228) released its financial report for the period ending December 31, 2025, expecting revenue to reach 800 million yuan in 2025, a year-on-year increase of 201%. Among them, revenue from drug discovery solutions is expected to be 538 million yuan, an increase of 418.9%; revenue from AI for Science smart solutions is expected to be 265 million yuan, an increase of 62.6%. Operating profit is expected to be 55.24 million yuan, a significant improvement compared to a loss of 684 million yuan in the same period last year. The company completed the issuance of zero-coupon convertible bonds worth HKD 2.866 billion on January 28, 2026"
datetime: "2026-03-27T01:50:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280713323.md)
  - [en](https://longbridge.com/en/news/280713323.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280713323.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/280713323.md) | [繁體中文](https://longbridge.com/zh-HK/news/280713323.md)


# XTALPI expects revenue of 800 million in 2025: operating profit of 55.24 million, just issued HKD 2.9 billion bonds

LeiDi Network, Lei Jianping, March 27

XTALPI Co., Ltd. (abbreviated as "XTALPI", stock code: "2228") recently released its financial report for the period ending December 31, 2025. The report shows that XTALPI's revenue for 2025 is 800 million yuan, an increase of 201% compared to 266 million yuan in the same period last year.

XTALPI's revenue from drug discovery solutions in 2025 is 538 million yuan, a 418.9% increase from 104 million yuan in the same period last year, mainly due to multiple projects reaching milestone deliveries and increased revenue from our antibody business.

XTALPI's revenue from AI for Science smart solutions in 2025 is 265 million yuan, a 62.6% increase from 163 million yuan in the same period last year.

XTALPI's general and administrative expenses for 2025 are 410 million yuan, research and development expenses are 569 million yuan, sales and marketing expenses are 81.17 million yuan, other income is 50.89 million yuan, and total other income is 514 million yuan.

XTALPI's operating profit for 2025 is 55.24 million yuan, compared to an operating loss of 684 million yuan in the same period last year; the profit for the year is 135 million yuan.

XTALPI's adjusted net profit for 2025 is 258 million yuan.

On January 28, 2026, XTALPI just completed the issuance of HKD 2.866 billion in zero-coupon convertible bonds.

As of December 31, 2025, XTALPI has a total of 1,254 employees.

———————————————

### 相关股票

- [XTALPI (02228.HK)](https://longbridge.com/zh-CN/quote/02228.HK.md)

## 相关资讯与研究

- [Meet 'Dobby': The AI agent that could kill the app economy](https://longbridge.com/zh-CN/news/281354277.md)
- [Legal AI startup Legora hits $100 million in annual recurring revenue](https://longbridge.com/zh-CN/news/281411319.md)
- [Realbotix to Deliver 19 AI Humanoid Robots as It Scales Production](https://longbridge.com/zh-CN/news/281387250.md)
- [Letter from the Editor Introducing AI Intelligence on American Banker](https://longbridge.com/zh-CN/news/281266312.md)
- [Insig AI Plans Growth Drive and Eyes Nasdaq Dual Listing](https://longbridge.com/zh-CN/news/281311983.md)